Short interest for Shineco gives investors a sense of the degree to which investors are betting on the decline of Shineco's stock. Short interest data is updated every two weeks.

Shineco Stock (NASDAQ:SISI), Short Interest Report

Shineco

Shineco Inc aims to care for a healthy life and improve the quality of life by providing safe, efficient, and high-quality health products and services to society. The company has researched and developed over 33 vitro diagnostic reagents and related medical devices to date, and it also produces and sells healthy and nutritious food.

News

Penny Stocks

Small Cap

Intraday Update

Markets

Movers

Trading Ideas

AMPL

ATCH

AVGR

BFRI

BLCO

CPOP

EFOI

GBNH

GRMN

HCKT

IOVA

JANX

LIVN

MOTS

MTTR

PANW

PLAB

RAPT

SEDG

SEED

SISI

SNCR

SOGP

TDOC

THRM

TRTX

UCAR

VTYX

WTTR

Shares of  International Flavors &amp; Fragrances Inc. (NYSE: IFF) fell during Wednesday’s session after the company reported mixed fourth-quarter financial results and reduced its expected quarterly dividend approximately 50% to 40 cents per share.

Why International Flavors &amp; Fragrances Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday&#39;s Mid-Day Session

Pre-Market Outlook

CNEY

MicroCloud Hologram Inc. - Ordinary Shares

HOLO

JXJT

LUNR

Shares of  NeoGenomics, Inc. (NASDAQ: NEO) rose sharply in today’s pre-market trading after the company reported better-than-expected fourth-quarter financial results and issued FY24 adjusted EPS guidance above estimates.

Why NeoGenomics Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket

AGRI

ANTE

BTCY

BTTX

CISO

CURO

EVLV

GXAI

INMD

LICN

LXRX

MEDS

MNPR

OCGN

OPEN

QBTS

QRTEA

SIEN

SMCI

SMMT

SPRC

SSRM

TANH

TIRX

TNYA

TVGN

VZIO

Shares of  Fluor Corporation (NYSE: FLR) fell during Tuesday’s session following fourth-quarter results.

Why Fluor Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Tuesday&#39;s Mid-Day Session

Shineco Inc

RBC Capital analyst Arun Viswanathan maintains FMC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>) with a Outperform and raises the price target from $65 to $81.

Price Target

Analyst Ratings

RBC Capital Maintains Outperform on FMC, Raises Price Target to $81

Wells Fargo analyst Praneeth Satish maintains Williams Companies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WMB#NYSE">WMB</a>) with a Equal-Weight and raises the price target from $37 to $38.

Wells Fargo Maintains Equal-Weight on Williams Companies, Raises Price Target to $38

Macro Economic Events

Economics

Federal Reserve

Director Of The National Economic Council Of The U.S. Brainard Says Debt Ceiling Fights Have Been Unproductive

Wells Fargo analyst Sarah Akers maintains Evergy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVRG#NASDAQ">EVRG</a>) with a Overweight and raises the price target from $57 to $62.

EVRG

Wells Fargo Maintains Overweight on Evergy, Raises Price Target to $62

RBC Capital analyst Christopher Carril maintains Planet Fitness (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLNT#NYSE">PLNT</a>) with a Outperform and lowers the price target from $80 to $77.

PLNT

RBC Capital Maintains Outperform on Planet Fitness, Lowers Price Target to $77

BMO Capital analyst Keith Bachman maintains TELUS Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TIXT#NYSE">TIXT</a>) with a Market Perform and lowers the price target from $9.5 to $7.5.

TIXT

BMO Capital Maintains Market Perform on TELUS Intl, Lowers Price Target to $7.5

Wells Fargo analyst Sarah Akers maintains Black Hills (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BKH#NYSE">BKH</a>) with a Equal-Weight and raises the price target from $56 to $61.

Wells Fargo Maintains Equal-Weight on Black Hills, Raises Price Target to $61

RBC Capital analyst Scott Hanold maintains SM Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SM#NYSE">SM</a>) with a Sector Perform and raises the price target from $50 to $54.

RBC Capital Maintains Sector Perform on SM Energy, Raises Price Target to $54

BMO Capital analyst Andrew Strelzik maintains Papa John's International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PZZA#NASDAQ">PZZA</a>) with a Outperform and lowers the price target from $80 to $75.

PZZA

BMO Capital Maintains Outperform on Papa John's International, Lowers Price Target to $75

Wells Fargo analyst Sarah Akers maintains Chesapeake Utilities (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CPK#NYSE">CPK</a>) with a Equal-Weight and raises the price target from $105 to $115.

Wells Fargo Maintains Equal-Weight on Chesapeake Utilities, Raises Price Target to $115

RBC Capital analyst Nik Modi maintains Spectrum Brands Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPB#NYSE">SPB</a>) with a Outperform and raises the price target from $100 to $114.

RBC Capital Maintains Outperform on Spectrum Brands Holdings, Raises Price Target to $114

BMO Capital analyst Keith Bachman maintains Genpact (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/G#NYSE">G</a>) with a Market Perform and lowers the price target from $39 to $38.

BMO Capital Maintains Market Perform on Genpact, Lowers Price Target to $38

RBC Capital analyst Christopher Carril maintains Sweetgreen (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SG#NYSE">SG</a>) with a Outperform and raises the price target from $20 to $35.

RBC Capital Maintains Outperform on Sweetgreen, Raises Price Target to $35

Wells Fargo analyst Sarah Akers maintains Atmos Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATO#NYSE">ATO</a>) with a Equal-Weight and raises the price target from $121 to $130.

Wells Fargo Maintains Equal-Weight on Atmos Energy, Raises Price Target to $130

BMO Capital analyst Etzer Darout maintains Fate Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FATE#NASDAQ">FATE</a>) with a Market Perform and lowers the price target from $7 to $6.

FATE

BMO Capital Maintains Market Perform on Fate Therapeutics, Lowers Price Target to $6

Wells Fargo analyst Chris Carey maintains Spectrum Brands Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPB#NYSE">SPB</a>) with a Equal-Weight and raises the price target from $85 to $95.

Wells Fargo Maintains Equal-Weight on Spectrum Brands Holdings, Raises Price Target to $95

BMO Capital analyst James Fotheringham maintains Affirm Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AFRM#NASDAQ">AFRM</a>) with a Market Perform and lowers the price target from $48 to $46.

AFRM

BMO Capital Maintains Market Perform on Affirm Holdings, Lowers Price Target to $46

<a href="https://www.wsj.com/economy/trade/biden-to-quadruple-tariffs-on-chinese-evs-203127bf">https://www.wsj.com/economy/trade/biden-to-quadruple-tariffs-on-chinese-evs-203127bf</a>
&nbsp;

Global

BYDDF

XPEV

'Biden To Quadruple Tariffs On Chinese EVs From 25% To 100%; Administration Is Preparing To Announce Higher Levies On A Range Of Chinese Goods Next Week' - WSJ

RBC Capital analyst Mike Dahl maintains Installed Building Prods (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IBP#NYSE">IBP</a>) with a Sector Perform and raises the price target from $216 to $220.

RBC Capital Maintains Sector Perform on Installed Building Prods, Raises Price Target to $220

Editor&#8217;s Note: We have updated the story with the latest estimates, which translate to a revenue beat. The estimates used in the original article were outdated.
Madison Square Garden Entertainment Corp.&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSGE#NYSE">MSGE</a>) shares are trading lower after it reported&nbsp;<a href="https://www.benzinga.com/pressreleases/24/05/n38727521/madison-square-garden-entertainment-corp-reports-fiscal-2024-third-quarter-results" target="_blank" rel="noreferrer noopener">third-quarter FY24 results</a>.
Revenue rose 13% Y/Y to $228.3 million, beating the analyst consensus of $227.6 million.&nbsp;
Revenues from entertainment offerings rose&nbsp;13% Y/Y to $146.2 million,&nbsp;led by higher event-related revenues and revenues subject to the sharing of economics with MSG Sports&nbsp;pursuant to&nbsp;the Arena License Agreements.&nbsp;
Food, beverage, and merchandise revenues increased 14% Y/Y to $45.4 million, aided by&nbsp;a higher number of&nbsp;concerts held at the venues and the impact of five more Knicks home games.
Event-related revenues increased $10.7 million compared to the prior year, aided by an increase in the number of concerts at the venues.
In addition, the&nbsp;company&nbsp;reported an adjusted operating income of $38.5 million, down 23% Y/Y, in the&nbsp;quarter,&nbsp;due to higher selling, general&nbsp;and&nbsp;administrative expenses.&nbsp;
EPS&nbsp;$0.06&nbsp;missed <a href="https://www.benzinga.com/calendars/earnings" target="_blank" rel="noreferrer noopener">the consensus of&nbsp;$0.11</a>.
As of March-end, cash and equivalents&nbsp;stood&nbsp;at $28.3 million.
Outlook: Madison Square Garden raised the lower end of FY24 sales guidance, revising the range to $940 million-$950 million (<a href="https://www.benzinga.com/news/earnings/24/02/36986416/madison-square-garden-q2-earnings-beats-estimates-on-higher-concerts-live-entertainment-sporting-ev" target="_blank" rel="noreferrer noopener">from $930 million-$950 million</a>) vs. $942.40 million estimate.
Also, the company increased&nbsp;adjusted&nbsp;operating income outlook to&nbsp;$200 million-$210 million from&nbsp;<a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">$195 million-$205 million in FY24</a>.
The company remains on track to achieve a low double-digit percentage increase in the number of&nbsp;bookings&nbsp;events in FY24.
Investors can gain exposure to the stock via&nbsp;Zacks Trust Zacks Small/Mid Cap ETF&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMIZ#NYSE">SMIZ</a>).
Price Action:&nbsp;MSGE shares are down 5.44% to $37.71 at&nbsp;the last check Thursday.
Photo via Wikimedia Commons

Earnings

Equities

Guidance

MSGE

SMIZ

Why Is Madison Square Garden Stock Down Thursday? (CORRECTED)

These Consumer Defensive stocks are trading higher:-Bit Origin Ltd (BTOG) stock is trading at $6.13, a gain of $1.16, or 23.34%, on high volume.  Bit Origin Ltd gets a Sentiment Score of Very Bearish from InvestorsObserver.  -Zevia Pbc (ZVIA) stock is trading at $1.62, a gain of $0.14, or 9.46%, on low volume.  Zevia Pbc C

Consumer Defensive Stocks Moving Up and Down Friday: BTOG, ZVIA, BIG, SFM, AMBO, FMX, SISI, PETZ

These Consumer Defensive stocks are trading higher:-Celsius Holdings, Inc. (CELH) stock is trading at $81.75, an increase of $13.98, or 19.76%, on high volume.  Celsius Holdings Inc gets a Sentiment Score of Bullish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $

Consumer Defensive Stocks Making Moves Thursday: CELH, BYND, STRA, STKL, DDL, ABEV, SISI, ZVIA

Shineco Inc (SISI) stock has fallen 11.02% over the past week and gets a Bearish rating from InvestorsObserver Sentiment Indicator. Shineco Inc has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on SISI!See Full SISI ReportWhat is Stock Sentiment?When making investment decisi

Do Traders Think Shineco Inc (SISI) Can Turn Around Friday?

Shineco Inc (SISI) stock is lower by -86.63% over the last 12 months. InvestorsObserverâ€&#x2122;s proprietary ranking system, gives SISI stock a score of  8 out of a possible 100. That rank is chiefly influenced by a short-term technical score of 1. SISI's rank also includes a long-term technical score of 23.  SISI has an Overall

Is Shineco Inc (SISI) Stock a Smart Investment Monday?

Shineco Inc (SISI) is down -3.77%% today. SISI has an Overall Score of 9. Find out what this means to you and get the rest of the rankings on SISI!See Full SISI ReportSISI stock closed at $1.06 and is down -$0.04 during pre-market trading. Pre-market tends to be more volatile due to significantly lower volume as most inves

Should You Hold Shineco Inc (SISI) Stock Tuesday Morning?

Shineco Inc (SISI) is near the bottom in its sector according to InvestorsObserver.SISI gets an overall rating of 4. That means it scores higher than 4% of stocks.Shineco Inc gets a 7 rank in the Consumer Defensive sector. Consumer Defensive is number 7 out of 11 sectors. SISI has an Overall Score of 4. Find out what this

Is Shineco Inc (SISI) a Loser in the Consumer Defensive Sector?

These Consumer Defensive stocks are trading higher:-Honest Company Inc (HNST) stock is trading at $3.95, a rise of $0.8, or 25.75%, on high volume.  The Honest Company gets a Sentiment Score of Bullish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $2.65.  -BRC In

Consumer Defensive Stocks Moving Thursday: HNST, BRCC, SISI, FPAFY, APEI, GROV, CLEU, QSG

Shineco regains compliance with Nasdaq minimum bid price rule

BTOG, MESO and SGLY among pre-market losers

Shineco Inc (SISI) stock is lower by -84.64% over the last 12 months. InvestorsObserverâ€&#x2122;s proprietary ranking system, gives SISI stock a score of  9 out of a possible 100. That rank is chiefly influenced by a short-term technical score of 4. SISI's rank also includes a long-term technical score of 22.  SISI has an Overall

Is Shineco Inc (SISI) Stock Worth a Buy Wednesday?

ABEV

AIRE

AMBO

APEI

BRCC

BTOG

BYND

CELH

CLEU

DLTR

ECDA

FPAFY

GROV

HNRA

HNST

MESO

NUKK

PETZ

PIII

SGLY

STKL

STRA

SURG

SWIM

WORX

ZCMD

ZVIA

Press Releases

Shineco Enters into Cooperation Agreement with Kangling Medical to Develop New Medical Products Company

Shineco Subsidiary Receives Marketing Approval from China's Regulatory Body for its Cardiac 5-Minute Test

Nano-Cap Medical Watchlist (TBRIF, CLRB, AVTX, SISI)

Shineco to Increase R&D to Explore New High-Tech Medical Product Applications

Shineco Opens Healthy Food Restaurant with Focus on Advanced Nutrition

Shineco Announces the Appointment of Two New Executive Officers

Shineco Announces 1-for-10 Reverse Stock Split to Regain Compliance with Nasdaq Minimum Bid Requirement

Opinion

Thinking about buying stock in Iovance Biotherapeutics, Alaska Energy Metals, Foremost Lithium Resource & Technology, Shineco, or Intuitive Machines?

Shineco Regains Compliance with Nasdaq Minimum Bid Price Requirement

Shineco Develops Revolutionary New Product with Varied Applications to Positively Impact the Health Care Industry

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Shineco Stock (NASDAQ:SISI), Short Interest Report

People Also Watch